Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Apr 16 2014Proprietary Products Revenue Grew 71% Over Q1 2013
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Apr 02 2014Autologous Cells Modified with Licensed T Cell Receptor (TCR) IP from University of Pennsylvania Studied for Safety, Bioactivity, and Effectiveness to Treat Multiple Myeloma
BOTHELL, WA — April 2, 2014 —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation...
- Mar 25 2014Common Stock to Begin Trading on NASDAQ Capital Market®
BioLife Solutions, Inc. (OTCQB: BLFS) today announced that is has closed a public offering of units for gross proceeds of approximately $15.4 million at a price of $4.30 per unit, completed the...
- Mar 20 2014
BioLife Solutions, Inc. (OTCQB: BLFS) today announced the pricing of a public offering and the entry into definitive agreements with purchasers for the sale of approximately 3.6 million units for...
- Mar 10 2014Nearly 50% of Presenting Companies are BioLife Customers
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Feb 25 2014
BioLife Solutions, Inc. (OTCQB: BLFSD), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Feb 12 20142014 Corporate Goals Include Uplisting to NASDAQ Capital Market® and Conversion of All Debt
BioLife Solutions, Inc. (OTCQB: BLFSD), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 29 2014HypoThermosol® Effective for Collection & Storage of Whole Blood and Components
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 21 2014Effective January 29, 2014; Intended to Facilitate NASDAQ Listing
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 09 2014Leading Manufacturer of Clinical Grade Biopreservation Media for Regenerative Medicine; Revenue Has Doubled Over the Last 2 Years to $9 Million in 2013; Report Available for Download at http://www.lifesciadvisors.com/clients/biolife
NEW YORK, NY--(Marketwired - Jan 9, 2014) - LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it...
- Jan 06 201458% Year over Year Growth Driven by Increased Adoption of Proprietary Products and Contract Manufacturing Services
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Dec 16 2013Authorization to Effect Reverse Stock Split; Debt Conversion Intended to Facilitate Potential Uplisting; Transactions Planned to Position Company for Growth and Improved Liquidity
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Dec 09 2013Discosphere™ Discogenic Stem-Like Progenitor Cells Hold Potential to Regenerate New Intervertebral Disc Material for Millions of Patients
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 19 2013Proven Medtech Executives Strengthen Board Stewardship as Company Positions for High Growth and Increased Shareholder Value
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 14 2013Company Achieves First Quarter of $1MM Core Product Revenue
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 13 2013Proprietary Biopreservation Media Products for Cells and Tissues Enabling Development of Lifesaving Therapies in the Global Regenerative Medicine Industry
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Sep 23 2013Nanoparticle-Based Precision Thermal Packaging Products Provide "Life Insurance" During Shipment of Sensitive Regenerative Medicine Biologic Source Material and Manufactured Cell and Tissue Products
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and...
- Sep 03 2013Proprietary, Clinical Grade Media Could Emerge as Gold Standard for Freezing, Storing, and Shipping Source Material and Manufactured Cell Products in High Growth Regenerative Medicine Market
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and...
- Aug 22 2013BioLife Solutions HypoThermosol® Embedded in Two Intercytex Clinical Trials of Cell-Based Wound CareProprietary Dermal Fibroblast-Based Product in HypoThermosol Could Greatly Improve Treatment of a Debilitating Skin Condition and also Burn Injuries
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Aug 13 2013CryoStor® cGMP Serum-Free, Protein-Free Freeze Media Used in Launch of More than 50 New Frozen Cell Products
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Aug 12 2013Company Achieves Twelfth Quarter of Consecutive Record Revenue Driven by Core Product Revenue of $0.9 Million
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 23 2013President and Chief Scientific Officer of NeoStem Subsidiary Progenitor Cell Therapy Joins Leading Clinicians, Developers, and Consultants in the High Growth Regenerative Medicine Market
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 10 2013
London, UK, 10 July 2013 – Lombard Medical Technologies PLC (AIM:LMT), the specialist medical technology company focussed on innovative vascular products, is pleased to announce the appointment...
- Jun 25 2013CryoStor® and HypoThermosol® Enable Improved Stability and Expanded Distribution of Blood Derived Cells for Research and Clinical Use
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jun 24 2013Award Based on Benefits, Team Member Surveys, Growth, Corporate Culture
BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 23 2013Presentation to Outline Risks in Using Non-Optimized Storage, Transport & Cryopreservation Media with Clinical Cell- and Tissue-Based Therapies
BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 14 2013Company Achieves Operating Income of $0.2 Million Driven by Organic Growth, Licensing Revenue
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 06 2013Continued Adoption of CryoStor® and HypoThermosol® in Clinical Applications
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 06 2013Continued Adoption of CryoStor® and HypoThermosol® in Clinical Applications
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 02 2013Custom Formulation of CryoStor® Cell Freeze Media Used in Clinical Trial of Cell Therapy
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Apr 01 2013Company Generated Positive Cash Flow From Operations in 2012
BOTHELL, WA— April 1, 2013 —BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze...
- Feb 04 2013CEO of Kirkland, WA-Based Cardiac Dimensions, Inc.
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jan 08 2013
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jan 07 2013Sales to All Strategic Market Segments up over 2011; Company Generated Positive Cash Flow From Operations in 2012
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jan 02 2013
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Dec 12 2012HypoThermosol Utilized as Combination Biopreservation Medium and Vehicle Solution for Therapeutic Cells
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 13 2012135% Year-over-Year Growth in Third Quarter Revenues; 2012 Full Year Revenue Guidance Increased to $5.0 Million
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Oct 29 2012Company's Novel Biopreservation Technology Recognized as Leading Choice For Commercialization In Emerging Field of Regenerative Medicine
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Oct 17 2012Combination of Cellenergy and BioLife's HypoThermosol® Storage and Shipping Media Demonstrates Improved Storage of Hair Grafts
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Sep 12 2012Company Estimates more than 60% of Attending Companies Are Customers
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Aug 14 20122012 Revenue Guidance Reiterated at $4.1 Million
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 23 2012Company Hiring to Support Increased Demand for Biopreservation Media Products, Contract Manufacturing Services
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 09 2012Sales of Proprietary Products and Contract Manufacturing Revenue Drive 31% Sequential, 76% Year-Over-Year Growth
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jun 01 2012Addendum Provides Financial Flexibility as Revenue Ramps
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 14 2012Gross Margin Increase; Facility Expansion Underway to Support New Manufacturing Agreement; Guidance of 50% Annual Revenue Growth
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Mar 26 2012Management Forecasts Revenue Growth of at Least 50% and Positive Cash Flow
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Mar 12 2012HypoThermosol® and CryoStor® Will Be Locally Available to the Broader European Research and Clinical Markets
PRLog (Press Release) – Mar 12, 2012 – tebu-bio, a leading distributor of reagents to the European research and clinical communities, today announced that it has executed a distribution...
- Mar 05 2012Demand for HypoThermosol® and CryoStor®, and New Contract Manufacturing Agreement Driving Growth and Creation of New Jobs
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues,...
- Feb 17 2012
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues,...
- Feb 06 2012Therapeutic Cells Are Frozen in CryoStor® GMP Cryopreservation Media, Shipped to the Clinic, Thawed and Injected into Cancer Patients
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues,...
We believe the promise of cell and gene therapies starts with the integrity of a single cell
Advancing the future of cell and gene therapy
The human body can heal itself. Cell and gene therapies are designed to augment the patient’s ability to fight disease but only if the living cells behind those therapies remain viable and functional throughout the production processes. At BioLife Solutions, our mission is to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. We believe the future of cell and gene therapies hinges on the integrity of every single cell and we are here to protect that promise.
We understand the technical demands of bioprocessing in this field, and our advanced biopreservation expertise, cell culture optimization products, innovative storage systems, and closed-system manufacturing solutions are designed to enhance process efficiency, maintain cellular viability, and ensure reproducibility at every stage. Whether scaling up from R&D, navigating clinical trials or optimizing cryopreservation protocols for commercial production, we provide the tools and experience to streamline your workflow and safeguard your therapies.
Streamline workflows and safeguard therapies
GMP-COMPATIBLE
Precision
biopreservation
for
maximum
viability
GMP-COMPATIBLE
Our biopreservation media and storage solutions are engineered to maintain cell integrity and functionality. With GMP-compatible, validated formulations, we help you reduce variability and improve post-thaw recovery, ensuring robust and reproducible outcomes.
CELL VIABILITY
Best
practices
in
cell
processing
CELL VIABILITY
With deep industry experience, regulatory support, and a commitment to innovation, BioLife Solutions is dedicated to supporting bioprocess engineers in overcoming complex manufacturing challenges. Whether optimizing cryopreservation protocols or ensuring the seamless transition from lab to clinic, we are dedicated to your success.
QUALITY & COMPLIANCE
Scalable
manufacturing
and
process
optimization
QUALITY & COMPLIANCE
Enhance efficiency and consistency in your cell processing workflow with our closed-system tools for fluid management and cell processing that are automation ready. Reduce manual handling errors, improve throughput, and achieve higher standards of quality and compliance as you scale towards commercialization.
REGULATORY SUPPORT
Your
partner
in
bioprocess
optimization
REGULATORY SUPPORT
BioLife Solutions delivers specialized tools and expertise to help bioprocess engineers streamline and strengthen biopreservation processes across the cell therapy workflow. From selecting the right biopreservation media to minimizing cell loss during freezing, storage, and transports, our solutions are designed to improve consistency, reduce risk, and support a successful transition from development to clinical application.
Work with experts who understand your biopreservation challenges
Connect with
our
experts
Explore
our
solutions
Collaborative and comprehensive CDMO support
At BioLife Solutions, we partner with leading contract development and manufacturing organizations (CDMOs) to enhance their biopreservation and cell processing capabilities. By providing advanced tools, regulatory support, and process optimization strategies, we empower CDMOs to better serve therapy developers, ensuring quality, consistency, and scalability in cell therapy manufacturing.
Regulatory
readiness
Navigating the complex regulatory landscape of cell and gene therapy requires a proactive approach. BioLife Solutions offers experienced regulatory support to help prepare your biopreservation and cell processing methods to meet global standards. From IND and BLA submissions to compliance with GMP, FDA, and EMA guidelines, our solutions help streamline approval pathways.
STORE
CellSeal®
CryoCase
Alleviate CGT container challenges like fracture risk, bag burping or high rates of particulates
Data-driven
decision making
Stay ahead with our comprehensive Evidence Library, a curated collection of scientific publications, white papers, and case studies demonstrating the efficacy of BioLife Solutions’ technologies. Access peer-reviewed research, real-world application data, and expert insights to support your bioprocessing and regulatory strategies.
